Covestor LTD Intra Cellular Therapies, Inc. Transaction History

Covestor LTD

$160 Million
Q4 2024

A detailed history of Covestor LTD transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Covestor LTD holds 2,099 shares of ITCI stock, worth $268,294. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,099

Previous 1,811 15.9%

Holding current value

$268,294

Previous $133,000 31.58%

% of portfolio

0.11%

Previous 0.08%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$71.19 - $91.57 $20,502 - $26,372	288 Added 15.9%	2,099 $175,000
Q3 2024 Nov 01, 2024	BUY	$67.99 - $80.84 $35,422 - $42,117	521 Added 40.39%	1,811 $133,000
Q2 2024 Aug 09, 2024	SELL	$64.76 - $79.84 $87,685 - $108,103	-1,354 Reduced 51.21%	1,290 $88,000
Q1 2024 May 10, 2024	SELL	$64.37 - $75.65 $11,844 - $13,919	-184 Reduced 6.51%	2,644 $183,000
Q4 2023 Feb 09, 2024	BUY	$46.37 - $73.65 $14,374 - $22,831	310 Added 12.31%	2,828 $203,000
Q3 2023 Nov 13, 2023	BUY	$52.09 - $64.1 $51,621 - $63,523	991 Added 64.9%	2,518 $131,000
Q2 2023 Aug 11, 2023	SELL	$54.67 - $66.44 $49,531 - $60,194	-906 Reduced 37.24%	1,527 $97,000
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $14,716 - $19,148	336 Added 16.02%	2,433 $132,000
Q4 2022 Feb 13, 2023	BUY	$44.07 - $54.45 $9,210 - $11,380	209 Added 11.07%	2,097 $110,000
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $72,547 - $101,923	1,699 Added 898.94%	1,888 $88,000
Q2 2022 Aug 10, 2022	BUY	$43.0 - $65.64 $7,611 - $11,618	177 Added 1475.0%	189 $11,000
Q1 2022 May 13, 2022	SELL	$38.74 - $62.09 $116 - $186	-3 Reduced 20.0%	12 $1,000
Q4 2021 Feb 10, 2022	BUY	$35.2 - $53.42 $528 - $801	15 New	15 $1,000

Others Institutions Holding ITCI

# of Institutions

415

Shares Held

88.5M

Call Options Held

284K

Put Options Held

105K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.1B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account